After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Integra Lifesciences Holdings Corp is $1.03B. A total of 0.86 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, GRAVES JEFFREY A bought 9,000 shares of IART for 11.35 per share on Nov 05 ’25. After the transaction, the Director now owns 41,086 company shares. In a previous transaction on Dec 03 ’24, Schwartz Eric sold 4,070 shares at 24.59 per share. IART shares that EVP, Chief Legal Officer & Sec owns now total 59,511.
Among the insiders who bought shares, Schwartz Eric acquired of 4,070 shares on Dec 03 ’24 at a per-share price of $24.59. In another insider transaction, McBreen Michael J. sold 1,700 shares at $24.16 per share on Dec 02 ’24. Company shares held by the EVP & President, CSS now total 56,182.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IART has a high of $27.13 and a low of $10.87.
As of this writing, IART has an earnings estimate of $0.8 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.82 per share and a lower estimate of $0.78. The company reported an EPS of $0.97 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IART’s latest balance sheet shows that the firm has $513.45M in Cash & Short Term Investments as of fiscal 2021. There were $1.65B in debt and $340.02M in liabilities at the time. Its Book Value Per Share was $13.33, while its Total Shareholder’s Equity was $1.68B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IART is Buy with a score of 3.00.
